| Authors: |
Labombarda F; Department of Cardiology, Normandie University, PSIR UNICAEN, CHU Caen-Normandie, Caen, France., Bodet D; Department of Pediatric Oncology and Hematology, CHU de Caen-Normandie, Caen, France., Rouger J; Department of Pediatric Oncology and Hematology, CHU de Caen-Normandie, Caen, France.; Imaging and Therapeutic Strategies for Cancers and Cerebral Tissues (ISTCT), Mixed Research Unit (UMR) 6030, OncoCARE Group, Caen, France., Guérin C; Service de Pharmacologie, CHU Caen-Normandie, Caen, France., Sassier M; Department of Pharmacology, CHU de Caen-Normandie, Caen, France., Chrétien B; International Medical Education Department, Graduate School of Medicine, Nagoya University, Nagoya, Japan., Alexandre J; PICARO Cardio-Oncology Program, Department of Cardiology, CHU de Caen-Normandie, Caen, France.; Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Caen, France.; PICARO Cardio-Oncology Program, Department of Pharmacology, CHU de Caen-Normandie, Caen, France.; Department of Pharmacology, 3 CHU de Caen-Normandie, Centre Régional de Pharmacovigilance, Caen, France., Dolladille C; Department of Pharmacology, 3 CHU de Caen-Normandie, Centre Régional de Pharmacovigilance, Caen, France.; Department of Pharmacology, 2 AP-HP, Pitié-Salpêtrière Hospital, CIC-1421, INSERM, UMR ICAN 1166, Sorbonne Université, APHP.6 Cardio-Oncology Program, Paris, France. |
